Fairvalue-Calculator Fairvalue-Calculator
EN DE

Cellyan Biotechnology Co (HKPD) Fair Value & Analysis

Healthcare · US · Market cap $9.3M

Price$0.3602
Fair Value$0.0400
Upside-88.9%
Quality87/100
Evidence: Medium Range $0.0400 – $0.0700

Fair value as of: Jun 25, 2026

✦ Find undervalued quality stocks — 34,000+ analysed Find stocks →

Analysis

Cellyan Biotechnology Co (HKPD) currently trades at $0.3602, while our model-based Fair Value estimate is $0.0400 — implying the stock looks roughly 88.9% overvalued today. We read business quality at 87/100 (high quality), in the Healthcare sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).

About the company

Cellyan Biotechnology Co., Ltd, an investment holding company, engages in the over the counter (OTC) pharmaceutical business in Hong Kong and Mainland China. The company provides OTC pharmaceutical cross-border procurement and distribution and e-commerce supply chain services. It also offers custom clearance, drugs enlisting, warehouse, and other logistics services. The company serves e-commerce platform logistics partners, merchants, and pharmaceutical distributors. The company was formerly known as Hong Kong Pharma Digital Technology Holdings Limited and changed its name to Cellyan Biotechnology Co., Ltd in December 2025. Cellyan Biotechnology Co., Ltd was incorporated in 2023 and is based in Yau Tong, Hong Kong.

Open the full interactive analysis →

Similar stocks

McKesson Corporation (M1CK34) -80% Cencora, Inc (C1CO34) -89% Cardinal Health, Inc (CAH) -36% Sigma Healthcare Limited (SIGGF) -67% Sitka Gold Corp (SIG) -59% Shanghai Pharmaceuticals Holding (601607) +183%

Frequently asked questions

Is Cellyan Biotechnology Co (HKPD) undervalued?
As of Jun 25, 2026, our model estimates a fair value of $0.0400 versus a price of $0.3602 — about −89% (overvalued). Model-based estimate, not financial advice.
What is the fair value of HKPD?
Our 21-model fair value for Cellyan Biotechnology Co is $0.0400 (as of Jun 25, 2026), built from audited fundamentals. The current price is $0.3602.
What is the quality score of HKPD?
Cellyan Biotechnology Co has a Quality Score of 87/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.